NCT02156271View on ClinicalTrials.gov

Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance

PHASE4CompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

June 30, 2008

Conditions

Insomnia

Interventions

DRUG

ramelteon

DRUG

placebo

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER